Pamnani M B, Haddy F J
Clin Exp Hypertens A. 1985;7(5-6):755-68. doi: 10.3109/10641968509077225.
Recent studies in our laboratories and in the laboratories of other investigators suggest the presence of a sodium-potassium pump inhibitor in the plasma of some patients with arterial hypertension. We here review these studies in an attempt to determine what characteristics increase the likelihood of detecting the inhibitor. The review suggests but does not prove that the inhibitor is most likely to be found in males with increased sodium intake, decreased renal function, and decreased plasma renin activity. In future studies of plasma sodium-potassium pump inhibitory activity in hypertensive humans, we should pay more attention to the characteristics of the patients. These characteristics include age, sex, race, therapy, stage of hypertension, sodium intake, renal function, and renin status. We should also make an attempt to match the patients properly with normotensive control subjects.
我们实验室以及其他研究人员实验室最近的研究表明,一些动脉高血压患者的血浆中存在钠钾泵抑制剂。我们在此回顾这些研究,试图确定哪些特征会增加检测到该抑制剂的可能性。该综述表明但未证明,抑制剂最有可能在钠摄入量增加、肾功能下降和血浆肾素活性降低的男性中发现。在未来对高血压患者血浆钠钾泵抑制活性的研究中,我们应更多地关注患者的特征。这些特征包括年龄、性别、种族、治疗方法、高血压阶段、钠摄入量、肾功能和肾素状态。我们还应尝试将患者与血压正常的对照对象进行合理匹配。